E

Evexia Lifecare Ltd

EVEXIA
Market snapshot · 2026-08-11 10:20 UTC

1.55

+₹0.02 (+1.31%)

MARKET CAP

₹290.99 Cr

STOCK P/E

155.0x

52W HIGH

₹2.42

52W LOW

₹0.47

BOOK VALUE

₹2.45

EPS

₹0.01

ROE

SECTOR

Healthcare

DEBT/EQUITY

VOLUME

32.64L

P/B RATIO

0.63x

PEG RATIO

Sector

Healthcare

Themes

Medical Distribution
₹2.31₹1.86₹1.40₹0.95₹0.49VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 31.9% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.95). Confidence: 66%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Undervalued

5Y Average

227.99

Current

155.00

Overvalued

270.00

Undervalued

168.00

P/S
Strongly Undervalued

5Y Average

4.20

Current

2.58

Overvalued

4.76

Undervalued

2.80

P/B
Strongly Undervalued

5Y Average

0.72

Current

0.63

Overvalued

0.82

Undervalued

0.61

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹30 CrJun 2026

Latest net profit

₹0.41 CrJun 2026

Latest EPS

₹0.00Jun 2026

Net margin

2.2%Jun 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.0%2.0%4.0%6.0%8.0%0.00 Cr9.00 Cr18 Cr27 Cr36 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.00 Cr9.00 Cr18 Cr27 Cr36 Cr₹0₹1₹2₹3₹4
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit0.00 Cr8.00 Cr16 Cr24 Cr32 Cr

Latest reported period: Jun 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025-300 Cr0.00 Cr300 Cr600 Cr900 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales +14.0210.486.7523.6520.4226.7121.5815.1820.6625.0324.6035.1829.66
Expenses +13.8210.146.7620.6719.9625.6221.3115.0919.7424.8224.1934.8629.01
Operating Profit0.200.34-0.012.980.461.090.270.090.920.210.410.320.65
OPM %1.43%3.24%-0.15%12.60%2.25%4.08%1.25%0.59%4.45%0.84%1.67%0.91%2.19%
Other Income +0.000.000.000.860.000.000.100.030.000.340.260.550.02
Interest0.000.01-0.010.490.000.050.000.310.010.000.000.000.00
Depreciation0.100.100.072.100.100.110.110.160.120.120.120.310.11
Profit before tax0.100.23-0.071.250.360.930.26-0.350.790.430.550.560.56
Tax %30.00%13.04%0.00%28.80%25.00%25.81%26.92%40.00%26.58%25.58%25.45%17.86%26.79%
Net Profit +0.070.20-0.070.890.260.690.19-0.490.590.320.410.470.41
EPS in Rs0.000.00-0.000.010.000.000.00-0.000.000.000.000.000.00
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters +3.49%3.49%3.36%3.49%3.36%
FIIs +0.16%0.47%0.47%0.12%
DIIs +0.09%0.09%0.09%0.09%0.09%
Public +96.25%96.40%96.07%95.94%96.41%
Others0.01%0.02%0.01%0.01%0.02%
Mar 2026
Promoters +
FIIs +
DIIs +
Public +
Others

Events Timeline

Announcement under Regulation 30 (LODR)-Newspaper Publication

Aug 08, 2026PDFCompany Reports Open

Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026

Aug 07, 2026PDFCompany Reports Open

Board Meeting Outcome for Outcome Of Board Meeting Held On August 07, 2026

Aug 07, 2026PDFCompany Reports Open

Corrigendum To Intimation Of Board Meeting To Be Held On Friday, August 07, 2026

Aug 05, 2026PDFCompany Reports Open

Board Meeting Intimation for To Consider And Approve Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended On June 30, 2026.

Aug 04, 2026PDFCompany Reports Open